2019 Bordetella pertussis Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 185 pages | ID: 2C70E14F653EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Bordetella pertussis Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Bordetella pertussis Infections. It presents in-depth analysis of Bordetella pertussis Infections clinical trials across markets and companies. The research work is for providing complete understanding into trends in Bordetella pertussis Infections.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Bordetella pertussis Infections clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Bordetella pertussis Infections

The research work is prepared through extensive and continuous research on Bordetella pertussis Infections trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Bordetella pertussis Infections patients are identified
• The report includes panorama of Bordetella pertussis Infections clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Bordetella pertussis Infections clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Bordetella pertussis Infections Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Bordetella pertussis Infections Clinical Trials by Region
  2.2.2 Average Enrollment of Bordetella pertussis Infections Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Bordetella pertussis Infections Treatment, 2019

3. REGION WISE BORDETELLA PERTUSSIS INFECTIONS CLINICAL TRIALS

3.1 Asia Pacific Bordetella pertussis Infections Clinical Trials by Country
3.2 Europe Bordetella pertussis Infections Clinical Trials by Country
3.3 North America Bordetella pertussis Infections Clinical Trials by Country
3.4 Middle East and Africa Bordetella pertussis Infections Clinical Trials by Country
3.5 South and Central America Bordetella pertussis Infections Clinical Trials by Country

4. BORDETELLA PERTUSSIS INFECTIONS CLINICAL TRIAL TRENDS

4.1 Start Year wise Bordetella pertussis Infections Clinical Trials
4.2 Phase wise Bordetella pertussis Infections Clinical Trials
4.3 Trial Status wise Bordetella pertussis Infections Clinical Trials
4.4 Trial Type wise Bordetella pertussis Infections Clinical Trials

5. BORDETELLA PERTUSSIS INFECTIONS AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Bordetella pertussis Infections Trials by Year
5.2 Average Enrollment in Bordetella pertussis Infections Trials by Phase
5.3 Average Enrollment in Bordetella pertussis Infections Trials by Status
5.4 Average Enrollment in Bordetella pertussis Infections Trials by Type of Trial

6. COMPANIES PARTICIPATING IN BORDETELLA PERTUSSIS INFECTIONS CLINICAL TRIALS

6.1 Bordetella pertussis Infections Trials by Sponsor Type
6.2 Bordetella pertussis Infections Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Bordetella pertussis Infections Trials- Phase
7.2 Bordetella pertussis Infections Trials- Phase
7.3 Bordetella pertussis Infections Trials- Phase
7.4 Bordetella pertussis Infections Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Bordetella pertussis Infections Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Figure 5: Europe – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Figure 7: North America – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Figure 9: Bordetella pertussis Infections Clinical Trials by Phase
Figure 10: Bordetella pertussis Infections Clinical Trials by Trial Status
Figure 11: Bordetella pertussis Infections Clinical Trials by Type
Figure 12: Bordetella pertussis Infections Clinical Trials by Sponsor Type
Figure 13: Bordetella pertussis Infections Clinical Trials by Leading Sponsors
Figure 14: Bordetella pertussis Infections Average Enrollment by Phase
Figure 15: Bordetella pertussis Infections Average Enrollment by Trial Status
Figure 16: Bordetella pertussis Infections Average Enrollment by Type
Figure 17: Bordetella pertussis Infections- Average Enrolment by Type of Sponsors
Figure 18: Bordetella pertussis Infections- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Bordetella pertussis Infections Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Table 5: Europe – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Table 7: North America – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Bordetella pertussis Infections Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Bordetella pertussis Infections Average Enrollment by Phase
Table 15: Bordetella pertussis Infections Average Enrollment by Trial Status
Table 16: Bordetella pertussis Infections Average Enrollment by Type
Table 17: Bordetella pertussis Infections- Average Enrolment by Type of Sponsors
Table 18: Bordetella pertussis Infections- Enrolment by Leading Sponsors